Accendra Health Inc (ACH)

$1.08 0.00 (N/A)
Market Cap 83.06M
Revenue (ttm) 2.76B
Net Income (ttm) -1.10B
EPS (ttm) N/A
PE Ratio 4.70
Forward PE N/A
Profit Margin -39.85%
Debt to Equity Ratio -3.12
Volume 1,030,000
Avg Vol 1,255,534
Day's Range N/A - N/A
Shares Out 76.91M
Stochastic %K 40%
Beta 1.53
Analysts Hold
Price Target $1.51

Company Profile

Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home med...

Industry: Medical Distribution
Sector: Healthcare
Phone: (804) 277-4304
Address:
4435 Waterfront Drive, Suite 300, Glen Allen, United States
EnergyAlphaCo
EnergyAlphaCo Sep. 11 at 11:59 PM
$ACH Watchlist Update: Coliseum Capital Files to Sell Most of Its ACH Position. Our thoughts noted in the comment section of our watchlist article: https://www.energyalphaco.com/p/accendra-health-the-debt-has-been
0 · Reply
spaarrow1
spaarrow1 Sep. 8 at 6:28 PM
$ACH why are they search ING for new ceo IF they go BK:)
1 · Reply
spaarrow1
spaarrow1 Aug. 26 at 1:41 PM
$ACH I sold and bought Gossamer instead.
0 · Reply
sh0rtkutz
sh0rtkutz Aug. 25 at 10:44 PM
$ACH 💯
0 · Reply
spaarrow1
spaarrow1 Aug. 21 at 8:28 AM
$ACH Guys listen. In 1.5 years this Company is debt free and IF they have 2.4 b revenue a year this Will be a 17-20 usd stock. And after 5 years they can have 60 billion in cash and can accumulate other companies. The this is a 100 usd stock. Imagine a 100x from 1.30 usd/share. This can be a monster stock. But u guys have to stop sellibg/buying. Only buy IF u can afford to be Long. I think this is a hidden gem. But Will Take 1.5 years til they are debt free. They took big loans to buy and improve the Company. This was a 40 usd stock just 3 years ago.
2 · Reply
STACKD0E
STACKD0E Aug. 20 at 5:08 PM
$ACH $NXTT $BRLS 👁
0 · Reply
spaarrow1
spaarrow1 Aug. 20 at 1:53 PM
$ACH Im in at 1.29
0 · Reply
BulldogTheDip
BulldogTheDip Aug. 19 at 7:20 PM
Picked up $ACH at 1.20
0 · Reply
Faizan9449
Faizan9449 Aug. 19 at 4:45 PM
$ACH 🤞🏻
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 19 at 2:20 PM
$ACH I told u... I told u... Easy money ✅
0 · Reply
Latest News on ACH
Accendra Health updates capital allocation, CEO succession plans

2026-08-17T10:35:11.000Z - 27 days ago

Accendra Health updates capital allocation, CEO succession plans

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans

Aug 17, 2026, 6:30 AM EDT - 27 days ago

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans

Accendra Health price target lowered to $1.50 from $4.50 at UBS

2026-08-17T07:52:55.000Z - 27 days ago

Accendra Health price target lowered to $1.50 from $4.50 at UBS

Accendra Health price target lowered to $1.30 from $2.70 at BofA

2026-08-11T13:25:12.000Z - 4 weeks ago

Accendra Health price target lowered to $1.30 from $2.70 at BofA

Accendra Health downgraded to Neutral from Outperform at Baird

2026-08-11T09:10:09.000Z - 4 weeks ago

Accendra Health downgraded to Neutral from Outperform at Baird

Accendra Health downgraded to Neutral from Buy at Citi

2026-08-10T20:30:29.000Z - 4 weeks ago

Accendra Health downgraded to Neutral from Buy at Citi

Accendra Health Earnings Call Transcript: Q2 2026

Aug 10, 2026, 8:00 AM EDT - 4 weeks ago

Accendra Health Earnings Call Transcript: Q2 2026

Accendra Health Slides: Q2 2026

Aug 10, 2026, 8:00 AM EDT - 4 weeks ago

Accendra Health Slides: Q2 2026

Accendra Health Earnings release: Q2 2026

Aug 10, 2026, 8:00 AM EDT - 4 weeks ago

Accendra Health Earnings release: Q2 2026

Accendra Health Quarterly report: Q2 2026

Aug 10, 2026, 8:00 AM EDT - 4 weeks ago

Accendra Health Quarterly report: Q2 2026

Accendra Health adopts Section 382 Rights Agreement

2026-08-10T10:55:43.000Z - 4 weeks ago

Accendra Health adopts Section 382 Rights Agreement

Accendra Health reports Q2 adjusted EPS (19c), consensus (9c)

2026-08-10T10:51:14.000Z - 4 weeks ago

Accendra Health reports Q2 adjusted EPS (19c), consensus (9c)

Accendra Health lowers FY26 revenue view to $2.45B-$2.55B from $2.55B-$2.65B

2026-08-10T10:50:27.000Z - 4 weeks ago

Accendra Health lowers FY26 revenue view to $2.45B-$2.55B from $2.55B-$2.65B

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Aug 10, 2026, 6:50 AM EDT - 4 weeks ago

Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value

Accendra Health Reports Second Quarter 2026 Financial Results

Aug 10, 2026, 6:45 AM EDT - 4 weeks ago

Accendra Health Reports Second Quarter 2026 Financial Results

Accendra Health’s President and CEO Ed Pesicka intends to retire after 2026

2026-08-10T10:42:35.000Z - 4 weeks ago

Accendra Health’s President and CEO Ed Pesicka intends to retire after 2026

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Aug 10, 2026, 6:30 AM EDT - 4 weeks ago

Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search

Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call

Jul 27, 2026, 9:15 AM EDT - 6 weeks ago

Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call

Accendra Health price target lowered to $4.50 from $5 at Citi

2026-07-24T10:40:25.000Z - 7 weeks ago

Accendra Health price target lowered to $4.50 from $5 at Citi

Accendra Health files $200M mixed securities shelf

2026-07-15T20:20:20.000Z - 2 months ago

Accendra Health files $200M mixed securities shelf

Accendra Health Registration statement: Registration filing

Jul 15, 2026, 8:00 AM EDT - 2 months ago

Accendra Health Registration statement: Registration filing

Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

Jun 23, 2026, 9:15 PM EDT - 2 months ago

Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations

Accendra Health Announces Early Results of Offers and Consent Solicitations

Jun 10, 2026, 6:30 AM EDT - 3 months ago

Accendra Health Announces Early Results of Offers and Consent Solicitations

Accendra Health Announces Offers and Consent Solicitations

May 22, 2026, 4:01 PM EDT - 3 months ago

Accendra Health Announces Offers and Consent Solicitations

Accendra Health Transcript: AGM 2026

May 14, 2026, 9:00 AM EDT - 4 months ago

Accendra Health Transcript: AGM 2026

Accendra Health price target raised to $4.50 from $3 at UBS

2026-05-12T14:31:15.000Z - 4 months ago

Accendra Health price target raised to $4.50 from $3 at UBS

Accendra Health price target raised to $6 from $5 at Baird

2026-05-12T11:40:36.000Z - 4 months ago

Accendra Health price target raised to $6 from $5 at Baird

Accendra Health price target raised to $5 from $3.25 at Citi

2026-05-12T10:41:20.000Z - 4 months ago

Accendra Health price target raised to $5 from $3.25 at Citi

Accendra Health Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Accendra Health Earnings Call Transcript: Q1 2026

Accendra Health Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Accendra Health Earnings release: Q1 2026

Accendra Health Slides: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Accendra Health Slides: Q1 2026

Accendra Health Quarterly report: Q1 2026

May 11, 2026, 8:30 AM EDT - 4 months ago

Accendra Health Quarterly report: Q1 2026

Accendra Health reports Q1 EPS (4c) vs. 29c last year

2026-05-11T11:18:41.000Z - 4 months ago

Accendra Health reports Q1 EPS (4c) vs. 29c last year

Accendra Health backs FY26 guidance for net revenue and adjusted EBITDA

2026-05-11T11:16:27.000Z - 4 months ago

Accendra Health backs FY26 guidance for net revenue and adjusted EBITDA

Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

May 11, 2026, 6:30 AM EDT - 4 months ago

Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call

May 1, 2026, 5:00 PM EDT - 4 months ago

Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call

Accendra Health Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 5 months ago

Accendra Health Proxy statement: Proxy filing

Accendra Health Proxy statement: Proxy filing

Apr 2, 2026, 8:00 AM EDT - 5 months ago

Accendra Health Proxy statement: Proxy filing

Accendra Health price target lowered to $3.25 from $4 at Citi

2026-02-23T11:47:57.000Z - 6 months ago

Accendra Health price target lowered to $3.25 from $4 at Citi

Accendra Health price target lowered to $3 from $4 at UBS

2026-02-22T19:21:11.000Z - 6 months ago

Accendra Health price target lowered to $3 from $4 at UBS

Accendra Health Earnings Call Transcript: Q4 2025

Feb 19, 2026, 5:00 PM EST - 6 months ago

Accendra Health Earnings Call Transcript: Q4 2025

Accendra Health Annual report: Q4 2025

Feb 19, 2026, 5:00 PM EST - 6 months ago

Accendra Health Annual report: Q4 2025

Accendra Health Earnings release: Q4 2025

Feb 19, 2026, 5:00 PM EST - 6 months ago

Accendra Health Earnings release: Q4 2025

Accendra Health Slides: Q4 2025

Feb 19, 2026, 5:00 PM EST - 6 months ago

Accendra Health Slides: Q4 2025

Accendra Health Annual report: Q4 2025

Feb 19, 2026, 5:00 PM EST - 6 months ago

Accendra Health Annual report: Q4 2025

Accendra Health Reports Fourth Quarter 2025 Financial Results

Feb 19, 2026, 4:05 PM EST - 6 months ago

Accendra Health Reports Fourth Quarter 2025 Financial Results

Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

Feb 5, 2026, 4:05 PM EST - 7 months ago

Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH”

Jan 2, 2026, 6:30 AM EST - 8 months ago

Accendra Health, Inc. to Begin Trading on NYSE under New Ticker “ACH”

Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity

Dec 31, 2025, 4:05 PM EST - 8 months ago

Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity

Owens & Minor Announces Corporate Name Change to Accendra Health, Inc.

Dec 18, 2025, 4:05 PM EST - 8 months ago

Owens & Minor Announces Corporate Name Change to Accendra Health, Inc.

Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025

Dec 2, 2025, 7:00 AM EST - 9 months ago

Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025

Accendra Health Earnings Call Transcript: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 10 months ago

Accendra Health Earnings Call Transcript: Q3 2025

Accendra Health Quarterly report: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 10 months ago

Accendra Health Quarterly report: Q3 2025

Accendra Health Earnings release: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 10 months ago

Accendra Health Earnings release: Q3 2025

Accendra Health Slides: Q3 2025

Oct 30, 2025, 5:00 PM EDT - 10 months ago

Accendra Health Slides: Q3 2025

Owens & Minor Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 4:05 PM EDT - 10 months ago

Owens & Minor Reports Third Quarter 2025 Financial Results

Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call

Oct 16, 2025, 6:30 AM EDT - 11 months ago

Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call

PLATINUM EQUITY TO ACQUIRE PRODUCTS & HEALTHCARE SERVICES BUSINESS FROM OWENS & MINOR

Oct 7, 2025, 4:21 PM EDT - 11 months ago

PLATINUM EQUITY TO ACQUIRE PRODUCTS & HEALTHCARE SERVICES BUSINESS FROM OWENS & MINOR

Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake

Oct 7, 2025, 4:15 PM EDT - 11 months ago

Owens & Minor Announces Definitive Agreement to Divest Products & Healthcare Services Segment to Platinum Equity for $375mm in Cash and a Retained Equity Stake

Apria and Byram Join New Optum Preferred DME Network

Sep 15, 2025, 4:45 PM EDT - 12 months ago

Apria and Byram Join New Optum Preferred DME Network

AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

Sep 5, 2025, 6:34 PM EDT - 1 year ago

AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

BGS EME HL MAN MP NE PUMP

Accendra Health Earnings Call Transcript: Q2 2025

Aug 11, 2025, 8:30 AM EDT - 1 year ago

Accendra Health Earnings Call Transcript: Q2 2025

Accendra Health Quarterly report: Q2 2025

Aug 11, 2025, 8:30 AM EDT - 1 year ago

Accendra Health Quarterly report: Q2 2025

Accendra Health Earnings release: Q2 2025

Aug 11, 2025, 8:30 AM EDT - 1 year ago

Accendra Health Earnings release: Q2 2025

Accendra Health Slides: Q2 2025

Aug 11, 2025, 8:30 AM EDT - 1 year ago

Accendra Health Slides: Q2 2025

Owens & Minor Reports Second Quarter 2025 Financial Results

Aug 11, 2025, 6:30 AM EDT - 1 year ago

Owens & Minor Reports Second Quarter 2025 Financial Results

Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call

Aug 4, 2025, 7:00 AM EDT - 1 year ago

Owens & Minor Announces Second Quarter 2025 Earnings Release Date and Conference Call

Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition

Jun 5, 2025, 9:00 AM EDT - 1 year ago

Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition

Accendra Health Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Accendra Health Earnings Call Transcript: Q1 2025

Accendra Health Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Accendra Health Quarterly report: Q1 2025

Accendra Health Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Accendra Health Earnings release: Q1 2025

Accendra Health Slides: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Accendra Health Slides: Q1 2025

Owens & Minor Reports First Quarter 2025 Financial Results

May 8, 2025, 6:30 AM EDT - 1 year ago

Owens & Minor Reports First Quarter 2025 Financial Results

Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call

May 1, 2025, 6:30 AM EDT - 1 year ago

Owens & Minor Announces First Quarter 2025 Earnings Release Date and Conference Call

Owens & Minor Announces Major Innovations to Products & Healthcare Services Network

Apr 9, 2025, 4:30 PM EDT - 1 year ago

Owens & Minor Announces Major Innovations to Products & Healthcare Services Network

Accendra Health Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Accendra Health Proxy statement: Proxy Filing

Accendra Health Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Accendra Health Proxy statement: Proxy Filing

Owens & Minor Announces Upsize and Pricing of Senior Secured Notes Offering

Apr 2, 2025, 5:28 PM EDT - 1 year ago

Owens & Minor Announces Upsize and Pricing of Senior Secured Notes Offering

Owens & Minor Announces Launch of Senior Secured Notes Offering

Mar 26, 2025, 4:44 PM EDT - 1 year ago

Owens & Minor Announces Launch of Senior Secured Notes Offering

Accendra Health Earnings Call Transcript: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Accendra Health Earnings Call Transcript: Q4 2024

Accendra Health Annual report: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Accendra Health Annual report: Q4 2024

Accendra Health Earnings release: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Accendra Health Earnings release: Q4 2024

Accendra Health Slides: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Accendra Health Slides: Q4 2024

Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment

Feb 28, 2025, 6:30 AM EST - 1 year ago

Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment

Owens & Minor Launches ByramConnect Digital Health Platform for Diabetes and Other Chronic Health Conditions

Feb 11, 2025, 6:30 AM EST - 1 year ago

Owens & Minor Launches ByramConnect Digital Health Platform for Diabetes and Other Chronic Health Conditions

EnergyAlphaCo
EnergyAlphaCo Sep. 11 at 11:59 PM
$ACH Watchlist Update: Coliseum Capital Files to Sell Most of Its ACH Position. Our thoughts noted in the comment section of our watchlist article: https://www.energyalphaco.com/p/accendra-health-the-debt-has-been
0 · Reply
spaarrow1
spaarrow1 Sep. 8 at 6:28 PM
$ACH why are they search ING for new ceo IF they go BK:)
1 · Reply
spaarrow1
spaarrow1 Aug. 26 at 1:41 PM
$ACH I sold and bought Gossamer instead.
0 · Reply
sh0rtkutz
sh0rtkutz Aug. 25 at 10:44 PM
$ACH 💯
0 · Reply
spaarrow1
spaarrow1 Aug. 21 at 8:28 AM
$ACH Guys listen. In 1.5 years this Company is debt free and IF they have 2.4 b revenue a year this Will be a 17-20 usd stock. And after 5 years they can have 60 billion in cash and can accumulate other companies. The this is a 100 usd stock. Imagine a 100x from 1.30 usd/share. This can be a monster stock. But u guys have to stop sellibg/buying. Only buy IF u can afford to be Long. I think this is a hidden gem. But Will Take 1.5 years til they are debt free. They took big loans to buy and improve the Company. This was a 40 usd stock just 3 years ago.
2 · Reply
STACKD0E
STACKD0E Aug. 20 at 5:08 PM
$ACH $NXTT $BRLS 👁
0 · Reply
spaarrow1
spaarrow1 Aug. 20 at 1:53 PM
$ACH Im in at 1.29
0 · Reply
BulldogTheDip
BulldogTheDip Aug. 19 at 7:20 PM
Picked up $ACH at 1.20
0 · Reply
Faizan9449
Faizan9449 Aug. 19 at 4:45 PM
$ACH 🤞🏻
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 19 at 2:20 PM
$ACH I told u... I told u... Easy money ✅
0 · Reply
Faizan9449
Faizan9449 Aug. 18 at 7:29 PM
$ACH
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Aug. 18 at 7:13 PM
$ACH No excuses....if you'd rather slave at a job for it that's ok.... I like it the easy way....awesome alert here onrhr adds.... I got others coming for tomorrow.... Break $1.10 for more here 🪭🪭🪭🪭
1 · Reply
FinDic
FinDic Aug. 17 at 1:02 PM
$ACH Just started a very small position in the premarket. This is positive news in the short term that buys them at least a few more quarters of liquidity and relieves short term pressure of BK. https://finance.yahoo.com/markets/stocks/articles/accendra-health-drops-equity-issuance-122915500.html
0 · Reply
Faizan9449
Faizan9449 Aug. 17 at 12:49 PM
$ACH
0 · Reply
elmono
elmono Aug. 14 at 11:37 PM
$ACH inevitable
1 · Reply
Ozyil
Ozyil Aug. 14 at 7:32 PM
$ACH at what price target is bottomed out for dip buy?
0 · Reply
MSG8898
MSG8898 Aug. 14 at 7:16 PM
$ACH on top of that, they still have 5% of the old company. They should immediately sell that stake and announce a bb programme, just the way Embecta did when anyone was screaming a potential BK ahead.
0 · Reply
MSG8898
MSG8898 Aug. 14 at 7:01 PM
$ACH a bit akward. My research estimates around 100-110M of NOL benefit plus deferred interest future savings (76+34) max. If a PE group steps in, they could scoop up a good company with about 2.45B in sales for 870M, paying down around 720M in debt, and 2$ per share (for a buyout price of 150M), with a total fiscal benefit of 100M on future profits. It just doesn't add up, leaving the new company with 1B of debt, 2.45B in sales, and the fiscal benefit.
0 · Reply
MSG8898
MSG8898 Aug. 14 at 1:48 PM
$ACH buying more. I wonder what shorts will do monday when they'll need to cover and noone will be selling in order to have the Aug. 20th timeline set. Lol.
0 · Reply
Aboudouh
Aboudouh Aug. 14 at 12:16 PM
$ACH bankruptcy is waiting in a corner Bk sooner or later
1 · Reply
MSG8898
MSG8898 Aug. 13 at 8:24 PM
$ACH in with a fraction of 1% of O/S. I am a believer.
0 · Reply
MSG8898
MSG8898 Aug. 13 at 6:34 PM
$ACH seriously, it's hard to get it. They reduced almost 400m in debt leaving roughly a lil more than 1.7B. It has huge sales with certainly lots of operating expenses to make it profitable, yet they sank from more than 3$ per share to 1$. A lil more execution on the operation side and this could go xbolic.
2 · Reply